A company whose clients are 83% female has raised $8.5 million to advance the future of gastrointestinal and metabolic care. New York City-based Salvo Health says its hybrid, AI-enhanced care model offers brick-and-mortar clinics a continuous care platform that improves patient outcomes, noting that it now has agreements with more than 800 gastroenterologists. “We see gut health as a missing ingredient in women’s health and mental health progress in this country,” says Katie Reinier Peykar, a partner in investor Torch Capital. “The disproportionate impact of chronic GI burdens (are) on women, reflecting the legacy of stigma and gaslighting, especially around IBS and obesity care.”

Keep Reading

View More
arrow-right